Cargando…

ELF5 and DOK7 regulation in anti-estrogen treated cells and tumors

BACKGROUND: Most women with primary breast cancers that express estrogen receptor alpha (ER or ESR1) are treated with endocrine therapies including the anti-estrogen tamoxifen, but resistance to these anti-endocrine therapies often develops. This study characterizes the expression of hormone recepto...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fitzgerald, Lily M., Browne, Eva P., Christie, Kevin D., Punska, Elizabeth C., Simmons, Leo O., Williams, Kristin E., Pentecost, Brian T., M. Jawale, Rahul, Otis, Christopher N., Arcaro, Kathleen F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Primary Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4754800/ https://www.ncbi.nlm.nih.gov/pubmed/26884724 http://dx.doi.org/10.1186/s12935-016-0282-9

Ejemplares similares

TROP2 methylation and expression in tamoxifen-resistant breast cancer
por: Zimmers, Stephanie M., et al.
Publicado: (2018)

Paralemmin-1 is over-expressed in estrogen-receptor positive breast cancers
por: Turk, Casey M, et al.
Publicado: (2012)

Role of Dok-1 and Dok-2 in Leukemia Suppression
por: Niki, Masaru, et al.
Publicado: (2004)

Dok-1 and Dok-2 are negative regulators of lipopolysaccharide-induced signaling
por: Shinohara, Hisaaki, et al.
Publicado: (2005)

Role of Dok-1 and Dok-2 in Myeloid Homeostasis and Suppression of Leukemia
por: Yasuda, Tomoharu, et al.
Publicado: (2004)

Long-term muscle-specific overexpression of DOK7 in mice using AAV9-tMCK-DOK7
por: Huang, Yu-Ting, et al.
Publicado: (2023)

ELF5 modulates the estrogen receptor cistrome in breast cancer
por: Piggin, Catherine L., et al.
Publicado: (2020)

Possible attenuation of the G2 DNA damage cell cycle checkpoint in HeLa cells by extremely low frequency (ELF) electromagnetic fields
por: Harris, Paul A, et al.
Publicado: (2002)

Novel p62dok family members, dok-4 and dok-5, are substrates of the c-Ret receptor tyrosine kinase and mediate neuronal differentiation
por: Grimm, Jan, et al.
Publicado: (2001)

Effects of expressing human T-cell leukemia virus type 1 (HTLV-I) oncoprotein Tax on DOK1, DOK2 and DOK3 gene expression in mice
por: OHSUGI, Takeo
Publicado: (2017)

Mechanism of disease and therapeutic rescue of Dok7 congenital myasthenia
por: Oury, Julien, et al.
Publicado: (2021)

SRSF1 suppresses selection of intron-distal 5′ splice site of DOK7 intron 4 to generate functional full-length Dok-7 protein
por: Ahsan, Khalid Bin, et al.
Publicado: (2017)

Estrogen mediated expression of nucleophosmin 1 in human endometrial carcinoma clinical stages through estrogen receptor-α signaling
por: Zhou, Yunxiao, et al.
Publicado: (2014)

Transactivation of the estrogen receptor promoter by BRCA1
por: Archey, William B., et al.
Publicado: (2017)

Expression and significance of DOK2 in colorectal cancer
por: WEN, XIANMEI, et al.
Publicado: (2015)

Estrogen receptor of primary breast cancers: evidence for intracellular proteolysis
por: Maaroufi, Younes, et al.
Publicado: (2000)

Characterization of MCF-12A cell phenotype, response to estrogens, and growth in 3D
por: Sweeney, Michael F., et al.
Publicado: (2018)

A mutation in DOK7 in congenital myasthenic syndrome forms aggresome in cultured cells, and reduces DOK7 expression and MuSK phosphorylation in patient-derived iPS cells
por: Zhang, Shaochuan, et al.
Publicado: (2022)

ELFE at CERN
por: Burkhardt, H
Publicado: (1999)

The ELFE programme and project
por: Laget, J M
Publicado: (1997)

ELF5 Suppresses Estrogen Sensitivity and Underpins the Acquisition of Antiestrogen Resistance in Luminal Breast Cancer
por: Kalyuga, Maria, et al.
Publicado: (2012)

Mutations in MUSK causing congenital myasthenic syndrome impair MuSK–Dok-7 interaction
por: Maselli, Ricardo A., et al.
Publicado: (2010)

DOK2 Inhibits EGFR-Mutated Lung Adenocarcinoma
por: Berger, Alice H., et al.
Publicado: (2013)

P53 and Beta-Catenin Activity during Estrogen treatment of Osteoblasts
por: Chandar, Nalini, et al.
Publicado: (2005)

Prediagnostic breast milk DNA methylation alterations in women who develop breast cancer
por: Salas, Lucas A, et al.
Publicado: (2020)

PLD1 is overexpressed in an ER-negative MCF-7 cell line variant and a subset of phospho-Akt-negative breast carcinomas
por: Gozgit, J M, et al.
Publicado: (2007)

The ELF4-ELF3-LUX Complex Links the Circadian Clock to Diurnal Control of Hypocotyl Growth
por: Nusinow, Dmitri A., et al.
Publicado: (2011)

ELF3, ELF5, EHF and SPDEF Transcription Factors in Tissue Homeostasis and Cancer
por: Luk, Ian Y., et al.
Publicado: (2018)

Curcumin inhibits leptin gene expression and secretion in breast cancer cells by estrogen receptors
por: Nejati-Koshki, Kazem, et al.
Publicado: (2014)

Increased ETV4 expression correlates with estrogen-enhanced proliferation and invasiveness of cholangiocarcinoma cells
por: Singsuksawat, Ekapot, et al.
Publicado: (2018)

Genetic polymorphisms of estrogen receptor genes are associated with breast cancer susceptibility in Chinese women
por: Dai, Zhijun, et al.
Publicado: (2019)

Congenital Myasthenic Syndrome due to DOK7 mutations in a family from Chile
por: Bevilacqua, Jorge A., et al.
Publicado: (2017)

Intragenic DOK7 deletion detected by whole-genome sequencing in congenital myasthenic syndromes
por: Azuma, Yoshiteru, et al.
Publicado: (2017)

ELFE: an electron laboratory for Europe
por: Laget, J M
Publicado: (1995)

DOK3 Negatively Regulates LPS Responses and Endotoxin Tolerance
por: Peng, Qisheng, et al.
Publicado: (2012)

The Nursery Elf (Poetry)
Publicado: (1881)

Comparative Investigation of Combined Metabolomics-Flavoromics during the Ripening of Mango (Mangifera indica L.) cv. ‘Nam Dok Mai Si Thong’ and ‘Nam Dok Mai No. 4’
por: Lin Aung, Ye, et al.
Publicado: (2021)

Altered expression of estrogen receptor-α variant messenger RNAs between adjacent normal breast and breast tumor tissues
por: Leygue, Etienne, et al.
Publicado: (2000)

Increased cell survival by inhibition of BRCA1 using an antisense approach in an estrogen responsive ovarian carcinoma cell line
por: Annab, Lois A, et al.
Publicado: (2000)

DOK7 gene therapy enhances motor activity and life span in ALS model mice
por: Miyoshi, Sadanori, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_be3s93j05ndpstf6db7snvc62j